TLR9 and systemic lupus erythematosus: For instance, excessive NETs formation has been linked to disease severity in SLE, where the LL-37-DNA complex within NETs structures activates TLR9-mediated B cell responses, leading to polyclonal B cell activation, increased antibody production, and exacerbation of inflammation in SLE patients (51).